The spread of COVID-19 continues to impact both our personal and professional lives. FUJIFILM Irvine Scientific implemented our Business Continuity Plans designed to address the effects of business interruption in a crisis. As part of these plans, in January we began taking extra steps to mitigate risks from the spread of coronavirus (SARS-CoV-2). FUJIFILM Irvine Scientific is continuously monitoring the situation to take all available actions to continue delivering products and services to our customers.
First, we want to assure you that our global sites are open and continuing to operate as expected. We recognize our products are essential raw materials for life saving therapies, vaccines, and diagnostics and are committed to take whatever actions we can to continue delivering products and services to our customers.
We have taken steps to ensure the safety of our employees such as implementing policies to maintain social distance, and following CDC and WHO guidelines on how to prevent infection. We are working closely with our supply chain, logistics and business partners to minimize risks of disruption.
We understand the volatility of today’s markets is creating anxiety. FUJIFILM Irvine Scientific is secure and backed by the strength of FUJIFILM Holdings, a Fortune 500 company. FUJIFILM brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields including, healthcare, graphic systems, highly functional materials, optical devices, digital imaging, and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic, and imaging technologies. FUJIFILM has global revenues of $22 billion.1
We will continue to monitor the situation, follow guidelines from official health authorities, and take appropriate steps to protect supply.
Please send any questions regarding this situation to firstname.lastname@example.org.
President and CEO
1For the year ended March 31, 2019, the company had global revenues of $22 billion at an exchange rate of 111 yen to the dollar.